Randomized controlled trial of tolvaptan and carperitide to fluid retention in patients with congestive heart failure

Trial Profile

Randomized controlled trial of tolvaptan and carperitide to fluid retention in patients with congestive heart failure

Completed
Phase of Trial: Phase III

Latest Information Update: 12 May 2016

At a glance

  • Drugs Tolvaptan (Primary) ; Carperitide
  • Indications Decompensated heart failure
  • Focus Therapeutic Use
  • Acronyms AVCMA
  • Most Recent Events

    • 17 Nov 2013 Results of an analysis based on LVEF presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 17 Nov 2013 Status changed from recruiting to completed.
    • 04 Sep 2013 Primary endpoint 'Urinary-output' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top